If you sell supplements online, you've met the wall: an ad set that won't approve, an account that gets restricted, a campaign that ran fine yesterday and is disabled today. It feels arbitrary. It mostly isn't.
Meta and Google reject supplement ads for a small, predictable set of reasons — and once you understand them, the path to approval stops looking like luck.
It's the funnel, not the product
The first thing to internalize: the platforms are rarely objecting to your product existing. They're objecting to how it's being sold in the ad, on the pre-lander, and on the landing page. Selling a legal supplement is fine. Implying it cures a disease is not. The rejection is a claims problem wearing a product-problem costume.
That distinction matters because it means the fix is in your control. You can't make the platform love your category, but you can build a funnel that gives it no reason to say no.
The claims that trip review
Most rejections cluster around a few claim types:
Disease and medical claims. Anything that positions a supplement as treating, curing or preventing a medical condition. "Cures anxiety," "reverses diabetes," "melts fat" — these are instant flags, and the bar is lower than most advertisers expect. Implication counts, not just literal wording.
Before-and-after and body imagery. Dramatic transformation photos, close-ups of body parts, and imagery that implies unrealistic or idealized outcomes. This is a leading cause of rejection in weight-loss and men's health especially.
Personal attributes. Copy that implies the platform knows something personal about the viewer — "struggling with your weight?", "at your age…" — violates personalized-attribute rules even when it feels innocuous.
Unsubstantiated superlatives. "Miracle," "guaranteed," "clinically proven" without the substantiation to back it. Guarantees and absolute promises draw scrutiny.
How compliant funnels get approved
The brands that scale in regulated categories don't fight the rules — they build for them from the first impression.
Lead with education, not the pitch. A pre-lander that informs — how a category works, what to look for, what the science does and doesn't say — gives the platform an approvable surface and warms the buyer at the same time. It also happens to convert better than a hard sell.
Match every layer. The ad, the pre-lander and the landing page have to tell a consistent, compliant story. A clean ad pointing at a landing page full of disease claims still gets you flagged; review looks through the whole funnel.
Frame benefits responsibly. You can talk about what a product supports without claiming what it cures. "Formulated to support everyday vitality" is a different regulatory object than "fixes low testosterone," even though they're selling to the same person.
Design for the long account, not the single campaign. A funnel built to just barely sneak through gets caught on the next review pass. One built to genuinely comply stays live, which is the only state in which scale is possible.
The categories where this bites hardest
Some verticals live permanently under this pressure. Men's health is the sharpest example — potency, testosterone and vitality products face the tightest filters anywhere, which is why we treat men's health lead generation as a compliance discipline first and a performance one second. Weight loss, sexual wellness and anything adjacent to a medical condition sit in the same territory.
In markets like India, platform policy stacks on top of local advertising standards, so the compliant-funnel discipline matters even more.
The takeaway
Rejection isn't a verdict on your product — it's feedback on your funnel. Build the funnel to inform rather than overclaim, keep every layer consistent, and frame benefits within the rules, and approval stops being a gamble. That's the difference between an account that resets every fortnight and one that compounds.
That compliant-first approach is exactly how we keep supplement accounts live at scale. If that's the problem you're fighting, start a brief and we'll walk through your funnel.